NCT03934996

Brief Summary

The main objective is to analyze the relationship between the PF muscles and the other variables along the different tasks of daily life and during the race.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
7mo left

Started Jun 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Jun 2021Dec 2026

First Submitted

Initial submission to the registry

April 22, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 2, 2019

Completed
2.1 years until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

June 21, 2024

Status Verified

June 1, 2024

Enrollment Period

5.1 years

First QC Date

April 22, 2019

Last Update Submit

June 19, 2024

Conditions

Keywords

pelvic floorathletes

Outcome Measures

Primary Outcomes (12)

  • Change %MVC

    Change % of Maximun voluntary contraction

    Prior and after intervention, an average of 12 weeks

  • Change of Base Tone of Pelvic Floor Muscles (EMG)

    Electromyography of base tone of Pelvic Floor Muscles

    baseline, prior and after intervention, an average of 12 weeks

  • Change of step length

    Metres of the step length. It will measure with two cinematic shimmers wich will be placed on both tibias.

    Prior and after intervention, an average of 12 weeks

  • Change of cadence

    steps/secons. It will measure with two cinematic shimmers wich will be placed on both tibias.It will measure with a cinematic shimmer wich will be placed on both tibias.

    Prior and after intervention, an average of 12 weeks

  • Change of ground reaction force

    Newton of the ground reaction force. It will measure with two cinematic shimmers wich will be placed on both tibias.

    Prior and after intervention, an average of 12 weeks

  • Change of acceleration

    Change of Acceleration (m/s2 axes X, Y, Z). It will measure with a EXG shimmer wich will be placed on the sternun.

    Prior and after intervention, an average of 12 weeks

  • Change of displacement

    metres of displacement. It will measure with two cinematic shimmers wich will be placed on both tibias.

    Prior and after intervention, an average of 12 weeks

  • Change of accumulated fatigue

    Using Lactate Pro 2. Mmol/Litres

    Prior and after intervention, an average of 12 weeks

  • Change of heart rate

    Heart Rate

    Prior and after intervention, an average 12 weeks

  • Perineometry of MCV

    perineometry of MCV using PFX

    baseline, prior and after intervention, an average of 12 weeks

  • Intravaginal manual palpation

    manual testing of the levator ani muscles using scale of Daniels

    baseline, prior and after intervention, an average of 12 weeks

  • Change of electromyography of Pelvic Floor Muscles

    Change of electromyography of Pelvic Floor Muscles

    Prior and after intervention, an average of 12 weeks

Secondary Outcomes (2)

  • Change Pelvic floor functional capacity

    Prior and after intervention, an average of 12 weeks

  • Quality of life score

    Prior and after intervention, an average of 12 weeks

Study Arms (2)

Assesment Runners

NO INTERVENTION

Healthy woman between 25 and 44 years old, not pregnant and running at least 10 km/week.

Runners with educational training

EXPERIMENTAL

Healthy woman between 25 and 44 years old, not pregnant and running at least 10 km/week with educational training about pelvic floor muscles.

Other: Runners with educational training

Interventions

Intervention will consist of an educational talk to know the anatomy and function of the Pelvic Floor Muscles and 20 minutes of both strength and endurance exercises with biofeedback. An exercise protocol will be carried out. The participants will be instruct to contract and maintain maximum force for a mean period of 6 seconds (endurance training) and rest for twice the length of the endurance training time, followed by three fast contractions in a row as strength training. It will be done twice a week, during 12 weeks. Pelvic floor assesment: Perineometry, manual palpation, electromyography Trunk and lower limbs electromyography and kinematics

Runners with educational training

Eligibility Criteria

Age25 Years - 44 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy woman between 25 and 44 years old.
  • Women not pregnant.
  • Women who run at least 10 km / week.
  • In case of having children, it has to be 12 months after childbirth, having had the first postpartum menstruation and having left breastfeeding.

You may not qualify if:

  • Women Pregnant or suspected of it.
  • Postpartum less than one year.
  • Having the period during the exploration for the classification in groups or during the day of the measurements.
  • Present operation in the urogenital region as well as any visceral or spinal operation.
  • Urinary tract and/or vaginal infections.
  • Vaginal lesions; anorectal lesions or bleeding.
  • Women with gynecological bleeding; urethral obstruction; fistulas; malformations (ectopic ureter, etc); genital prolapse.
  • Women with pain in Pelvic Floor or lower limbs or back.
  • Pain during the race.
  • Allergy to silver, nickel and/or latex.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Malaga

Málaga, 29009, Spain

Location

Related Publications (7)

  • Hagovska M, Svihra J, Bukova A, Horbacz A, Drackova D, Svihrova V, Kraus L. Prevalence of Urinary Incontinence in Females Performing High-Impact Exercises. Int J Sports Med. 2017 Mar;38(3):210-216. doi: 10.1055/s-0042-123045. Epub 2017 Feb 17.

    PMID: 28212587BACKGROUND
  • Chevalier F, Fernandez-Lao C, Cuesta-Vargas AI. Normal reference values of strength in pelvic floor muscle of women: a descriptive and inferential study. BMC Womens Health. 2014 Nov 25;14:143. doi: 10.1186/s12905-014-0143-4.

    PMID: 25420756BACKGROUND
  • Leitner M, Moser H, Eichelberger P, Kuhn A, Radlinger L. Evaluation of pelvic floor muscle activity during running in continent and incontinent women: An exploratory study. Neurourol Urodyn. 2017 Aug;36(6):1570-1576. doi: 10.1002/nau.23151. Epub 2016 Oct 29.

    PMID: 27794169BACKGROUND
  • Luginbuehl H, Naeff R, Zahnd A, Baeyens JP, Kuhn A, Radlinger L. Pelvic floor muscle electromyography during different running speeds: an exploratory and reliability study. Arch Gynecol Obstet. 2016 Jan;293(1):117-124. doi: 10.1007/s00404-015-3816-9. Epub 2015 Jul 21.

    PMID: 26193953BACKGROUND
  • Goldstick O, Constantini N. Urinary incontinence in physically active women and female athletes. Br J Sports Med. 2014 Feb;48(4):296-8. doi: 10.1136/bjsports-2012-091880. Epub 2013 May 18.

    PMID: 23687004BACKGROUND
  • Bo K. Urinary incontinence, pelvic floor dysfunction, exercise and sport. Sports Med. 2004;34(7):451-64. doi: 10.2165/00007256-200434070-00004.

    PMID: 15233598BACKGROUND
  • Carvalhais A, Da Roza T, Vilela S, Jorge RN, Bo K. Association Between Physical Activity Level and Pelvic Floor Muscle Variables in Women. Int J Sports Med. 2018 Dec;39(13):995-1000. doi: 10.1055/a-0596-7531. Epub 2018 Oct 16.

    PMID: 30326528BACKGROUND

MeSH Terms

Conditions

Pelvic Floor DisordersUrinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital DiseasesUrinary IncontinenceUrination DisordersUrologic DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The researcher will not know who belongs to each group
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Researcher of CTS631 University of Malaga

Study Record Dates

First Submitted

April 22, 2019

First Posted

May 2, 2019

Study Start

June 1, 2021

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

June 21, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations